Abstract:Clusterin (CLU) or APOJ is a multifunctional glycoprotein that has been implicated in several physiological and pathological states, including Alzheimer's disease (AD). With a prominent extracellular chaperone function, additional roles have been discussed for clusterin, including lipid transport and immune modulation, and it is involved in pathways common to several diseases such as cell death and survival, oxidative stress, and proteotoxic stress. Although clusterin is normally a secreted protein, it has also been found intracellularly under certain stress conditions. Multiple hypotheses have been proposed regarding the origin of intracellular clusterin, including specific biogenic processes leading to alternative transcripts and protein isoforms, but these lines of research are incomplete and contradictory. Current consensus is that intracellular clusterin is most likely to have exited the secretory pathway at some point or to have re-entered the cell after secretion. Clusterin's relationship with amyloid beta (Aβ) has been of great interest to the AD field, including clusterin's apparent role in altering Aβ aggregation and/or clearance. Additionally, clusterin has been more recently identified as a mediator of Aβ toxicity, as evidenced by the neuroprotective effect of CLU knockdown and knockout in rodent and human iPSC-derived neurons. CLU is also the third most significant genetic risk factor for late onset AD and several variants have been identified in CLU. Although the exact contribution of these variants to altered AD risk is unclear, some have been linked to altered CLU expression at both mRNA and protein levels, altered cognitive and memory function, and altered brain structure. The apparent complexity of clusterin's biogenesis, the lack of clarity over the origin of the intracellular clusterin species, and the number of pathophysiological functions attributed to clusterin have all contributed to the challenge of understanding the role of clusterin in AD pathophysiology. Here, we highlight clusterin's relevance to AD by discussing the evidence linking clusterin to AD, as well as drawing parallels on how the role of clusterin in other diseases and pathways may help us understand its biological function(s) in association with AD.

Advances in Research on the Role of Clusterin in Treatment of Human Malignancies

Clusterin: a New Therapeutic Target for Malignancies

Therapeutic Potential of Clusterin Inhibition in Human Cancer

Purification and Characterization of Secretory Clusterin Proteins from an Eukaryotic Expression System and the Preliminary Exploration of Its Functions

Clusterin Modulates Transdifferentiation of Non-Small-cell Lung Cancer

Clusterin Immuno-Expression and Its Clinical Significance in Patients with Non-Small Cell Lung Cancer.

Clusterin Protects Hepatocellular Carcinoma Cells from Endoplasmic Reticulum Stress Induced Apoptosis Through GRP78.

Decoding CLU (Clusterin): Conquering cancer treatment resistance and immunological barriers

The study of secretory clusterin on the biological behaviors of non-small cell lung cancer cells

Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.

Clusterin Facilitates Metastasis By Eif3i/Akt/Mmp13 Signaling In Hepatocellular Carcinoma

The therapeutic and prognostic role of clusterin in diverse musculoskeletal diseases: a mini review

Secreted Clusterin Inhibits Tumorigenesis by Modulating Tumor Cell and Macrophage in Human Meningioma

Inhibition Lysosomal Degradation of Clusterin by Protein Kinase D3 Promotes Triple‐Negative Breast Cancer Tumor Growth

Serum Clusterin As a Tumor Marker and Prognostic Factor for Patients with Esophageal Cancer.

Prevention of Cell Death in LNCaP Cells by Overexpression of Clusterin

Clusterin: a marker and mediator of chemoresistance in colorectal cancer

Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies

Clusterin contributes to hepatitis C virus-related hepatocellular carcinoma by regulating autophagy

Clusterin in Alzheimer’s disease: a player in the biological behavior of amyloid-beta

Clusterin Expression in EJ Cells and Its Antiapoptosis Mechanism